Methodological analysis evaluates safety assessments of continuous renal replacement therapy in acute-on-chronic liver failure, highlighting critical monitoring needs.
Key Points
To evaluate methodological considerations in the safety assessment of regional citrate anticoagulation compared with heparin during continuous renal replacement therapy in patients with acute-on-chronic liver failure.
Appraised clinical safety assessment methodologies in an Indian cohort of acute-on-chronic liver failure patients receiving continuous renal replacement therapy.
Compared protocols and adverse outcome tracking for regional citrate anticoagulation versus standard heparin administration.
Safety assessment protocols require rigorous standardization to account for altered citrate clearance and high bleeding risks in severe liver dysfunction.
Cohort data provide critical evidence for an underexplored clinical question in critical care nephrology and hepatology.